Drug Shortage Report for TARO-DICLOFENAC
Report ID | 202456 |
Drug Identification Number | 02420988 |
Brand name | TARO-DICLOFENAC |
Common or Proper name | DICLOFENAC |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 1.5% |
Dosage form(s) | SOLUTION |
Route of administration | TOPICAL TOPICAL |
Packaging size | 60mL |
ATC code | M02AA |
ATC description | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-10 |
Estimated end date | 2023-10-27 |
Actual end date | 2023-10-24 |
Shortage status | Resolved |
Updated date | 2023-10-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-10-25 | French | Compare |
v5 | 2023-10-25 | English | Compare |
v4 | 2023-08-30 | French | Compare |
v3 | 2023-08-30 | English | Compare |
v2 | 2023-08-18 | French | Compare |
v1 | 2023-08-18 | English | Compare |
Showing 1 to 6 of 6